News
$Enveric Biosciences(ENVB.US$ Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
Benzinga· 6 mins ago
Enveric Biosciences (NASDAQ:ENVB), a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding term sheet with an undisclosed biotech company (licensee) for an exclusive license to two patented methods aimed at treating breast cancer and other cancers. These methods utilize cannabinoids in combination with chemotherapeutic drugs.
As per the agreement, the licensee will obtain an exclusive, global license to these methods, along with any devices and drugs developed to implement them. The licensee will also take on all future preclinical and clinical development responsibilities on a royalty-bearing basis for both human and animal pharmaceutical applications.
Subject to certain conditions, the licensee will compensate Enveric with a License Execution Fee and provide development and sales milestones totaling up to $61 million. Additionally, Enveric will receive royalties ranging from 2.5% to 10% on all future sales. The licensee also retains a cash buyout option.
Benzinga· 6 mins ago
Enveric Biosciences (NASDAQ:ENVB), a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding term sheet with an undisclosed biotech company (licensee) for an exclusive license to two patented methods aimed at treating breast cancer and other cancers. These methods utilize cannabinoids in combination with chemotherapeutic drugs.
As per the agreement, the licensee will obtain an exclusive, global license to these methods, along with any devices and drugs developed to implement them. The licensee will also take on all future preclinical and clinical development responsibilities on a royalty-bearing basis for both human and animal pharmaceutical applications.
Subject to certain conditions, the licensee will compensate Enveric with a License Execution Fee and provide development and sales milestones totaling up to $61 million. Additionally, Enveric will receive royalties ranging from 2.5% to 10% on all future sales. The licensee also retains a cash buyout option.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
dSuu : let's do this
TrytosaveabitOP dSuu: Let's! Hehehe! GL
dSuu : TY and GL aswell.. few things in my ticker moving today.. starting off rite
TrytosaveabitOP dSuu: Very nice!
买跌不追涨 : Don't be like CNMD yesterday
TrytosaveabitOP 买跌不追涨: Sure please act like CMND! I’ll gladly jump out with 50/70% profit and won’t look back! Hehehe! Well at least until it falls in price again! Like I said before! Get in make money get out! Most that trade under 5/7 dollars never hold up long! So trade what they give and get out! Repeat! Hehehe